Trademark: 87277841
Word
T ACCESS
Status Date
Tuesday, January 23, 2024
Registration Number
5333339
Registration Date
Tuesday, November 14, 2017
Filing Date
Thursday, December 22, 2016
Published for Opposition
Tuesday, August 29, 2017
41 [ Educational services, namely, providing classes, courses, and seminars in the field of medicine and disease prevention; providing medical training; arranging and conducting seminars, educational conferences, symposiums, workshops and courses in the field of medicine and disease prevention; educational services, namely, providing classes, seminars, workshops, and training in the fields of scientific research and development in the fields of pharmaceuticals, science, pharmaceutical clinical studies, tests and trials, medical diagnostics, medicine, pharmaceuticals, medical disorders, diseases, and disease treatment and prevention; providing the aforementioned services electronically, via cable or Internet or other electronic media; arranging and conducting in-person educational forums in the fields of medicine and pharmaceuticals; on-line training programs in the fields of medicine and pharmaceuticals; providing temporary use of online non-downloadable publications in the nature of books, reports, brochures, booklets, leaflets, patient information leaflets, magazines, journals, and teaching and educational curriculum in the fields of medical and pharmaceutical research and development ]
5 [ Vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of dementia, Alzheimer's disease and disorder, dizziness, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, schizophrenia, bipolar disorder and disease, ADHD, cancer, pain, alcoholism and chemical dependency; diagnostic agents, reagents, preparations and substances for medical purposes ]
44 Medical services; healthcare services; therapeutic clinical services in the field of brain and central nervous systems diseases and disorders; providing medical and healthcare information; providing information in the field of the therapeutic properties of pharmaceuticals; psychiatry and clinical psychology services in the fields of central nervous system diseases and disorders; medical advice related to medical and pharmaceutical preparations and substances; healthcare and medical services related to central nervous system and brain disorders, diseases and pharmaceuticals; providing medical information in the field of diagnostics, medicine, pharmaceuticals, medical disorders, diseases, and disease treatment and prevention; providing online medical data and analyses designed to provide patients and clients with customized medical information regarding medical dosing, medical diagnoses, therapeutic counseling services, and non-surgical medical management of diseases and medical disorders
42 [ Scientific and technological services, namely, research and design in the field of medicine; industrial analysis and research services in the field of pharmaceuticals; providing temporary use of online non-downloadable software for accessing an online searchable database in the fields of medical research and development, science, clinical tests and trials, medical diagnostics, medicine, pharmaceuticals, medical disorders, diseases, and disease treatment and prevention; pharmaceutical research and development; scientific and technological services, namely, research in the fields of medical disorders, diseases, disease prevention, central nervous system, neurological disorders, and central nervous system disorders, diseases, and related pharmaceuticals; medical research, namely, conducting medical trials and tests for others in the field of pharmaceuticals; conducting clinical research, trials, and testing for others in the field of pharmaceuticals; medical diagnostic research and tests and clinical trials for others; providing medical and pharmaceutical information in the field of research and development, science, clinical trials and tests ]
The mark consists of a letter "t" and the word "access" in lowercase in orange letters with a blue-green curved arrow between the "t" pointing to the word "access". The white background is transparent and not claimed as a feature of the mark.
The color(s) blue-green and orange is/are claimed as a feature of the mark.
Mar 22, 2024
Teas Change Of Correspondence Received
Mar 22, 2024
Teas Change Of Domestic Representatives Address
Mar 22, 2024
Teas Withdrawal As Domestic Representative Received
Mar 22, 2024
Attorney/Dom.Rep.Revoked And/Or Appointed
Mar 22, 2024
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jan 23, 2024
Notice Of Acceptance Of Sec. 8 - E-Mailed
Jan 23, 2024
Registered - Partial Sec. 8 (6-Yr) Accepted
Jan 23, 2024
Case Assigned To Post Registration Paralegal
Nov 13, 2023
Teas Section 8 Received
Nov 14, 2022
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Nov 14, 2017
Registered-Principal Register
Aug 29, 2017
Official Gazette Publication Confirmation E-Mailed
Aug 29, 2017
Published For Opposition
Aug 9, 2017
Notification Of Notice Of Publication E-Mailed
Jul 19, 2017
Approved For Pub - Principal Register
Jul 19, 2017
Examiner's Amendment Entered
Jul 19, 2017
Notification Of Examiners Amendment E-Mailed
Jul 19, 2017
Examiners Amendment E-Mailed
Jul 19, 2017
Examiners Amendment -Written
Jul 5, 2017
Teas/Email Correspondence Entered
Jul 5, 2017
Correspondence Received In Law Office
Jun 29, 2017
Assigned To Lie
Jun 1, 2017
Teas Response To Office Action Received
Jun 1, 2017
Teas Change Of Correspondence Received
Mar 29, 2017
Notification Of Non-Final Action E-Mailed
Mar 29, 2017
Non-Final Action E-Mailed
Mar 29, 2017
Non-Final Action Written
Mar 23, 2017
Assigned To Examiner
Jan 6, 2017
Notice Of Design Search Code E-Mailed
Jan 5, 2017
New Application Office Supplied Data Entered
Dec 27, 2016
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
